Opiant Pharma (OPNT) PT Lowered to $41 at Oppenheimer
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Rating Summary:
0 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Rating Summary:
0 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Opiant Pharma (NASDAQ: OPNT) to $41.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Riskified Ltd. (RSKD) PT Raised to $7.50 at DA Davidson on Improving New Business Trends
- Murphy Oil Corp. (MUR) PT Lowered to $43 at KeyBanc
- Advance Auto Parts (AAP) PT Raised to $67 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
